We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (271)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (63)
- Manufacturing (52)
- Vaping hub (51)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Import and export (24)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (4)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
101 result(s) found, displaying 76 to 100
-
Media releasesThe TGA has issued three infringement notices to a Queensland man for the alleged unlawful importation of a medicine containing Armodafinil.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Compliance undertakingsEnforceable Undertaking given by Chemforce Pty Ltd to the Department of Health
-
Media releasesThe infringement notice relate to the alleged failure to provide information on a contact person responsible for medicine safety.
-
News articlesSunscreen SPF testing by AMA Laboratories - Regulatory update. Possible fraudulent testing of sunscreens and TGA efforts to mitigate effect on Australian consumers.
-
Regulatory decision noticesMr Leyonhjelm was directed to cease advertising a prescription medicine for the treatment of Covid-19.
-
Media releasesThe TGA has issued eight infringement notices to Sydney-based company for allegedly failing to provide information and face mask samples to the TGA when required to do so, and for providing false and misleading information.
-
Compliance undertakings
-
Media releasesThe TGA has issued eight infringement notices to Sydney-based company Shen Neng Herbal Medicines Group Pty Ltd in relation to supply, labelling and pharmacovigilance
-
Media releasesAdelaide woman fined $5,040 for alleged unlawful importation of cosmetic injections.
-
Media releasesThe TGA has issued two infringement notices totalling $25,200 to Sydney-based company Australian Chemical Research
-
Compliance undertakingsUndertaking given to the Secretary of the Australian Government Department of Health for the purposes of section 42YL of the Act
-
Media releasesThe TGA has issued twelve infringement notices totalling $151,200 for the alleged unlawful advertising of Miracle Mineral Supplement and other medicines
-
Media releasesThe Federal Court granted the interim injunction on 3 April 2020
-
Media releasesThe Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd
-
News articlesInformation for cannabis manufacturers regarding TGO 93
-
Regulatory decision noticesOn 20 November 2019 the TGA issued a direction notice to Cat Media concerning its advertising of Fatblaster Clinical
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
News articlesOn 14 December 2018, the TGA issued an infringement notice for export of unlawful medicines from Australia
-
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Media releasesIn reference to the ABC’s Fact Check article “Will the move to make codeine prescription-only save a100 lives a year” the Therapeutic Goods Administration (TGA) would like to clarify:
-
Media releasesThe TGA has imposed two new conditions on the inclusion of the SynchroMed II Programmable Pump in the Australian Register of Therapeutic Goods